Edesa Biotech, Inc.
EDSA
$2.43
$0.010.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 964.70K | 1.15M | 878.90K | 900.50K | 1.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.90M | 1.64M | 1.90M | 1.00M | 1.93M |
| Operating Income | -1.90M | -1.64M | -1.90M | -1.00M | -1.93M |
| Income Before Tax | -1.75M | -1.59M | -1.62M | -962.10K | -1.67M |
| Income Tax Expenses | -- | 800.00 | -- | 0.00 | -- |
| Earnings from Continuing Operations | -1.75M | -1.59M | -1.62M | -962.10K | -1.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.75M | -1.59M | -1.62M | -962.10K | -1.67M |
| EBIT | -1.90M | -1.64M | -1.90M | -1.00M | -1.93M |
| EBITDA | -1.88M | -1.61M | -1.86M | -976.90K | -1.88M |
| EPS Basic | -0.25 | -0.30 | -0.48 | -0.30 | -0.52 |
| Normalized Basic EPS | -0.17 | -0.19 | -0.36 | -0.19 | -0.37 |
| EPS Diluted | -0.25 | -0.30 | -0.48 | -0.30 | -0.52 |
| Normalized Diluted EPS | -0.17 | -0.19 | -0.36 | -0.19 | -0.37 |
| Average Basic Shares Outstanding | 7.02M | 5.31M | 3.35M | 3.25M | 3.22M |
| Average Diluted Shares Outstanding | 7.02M | 5.31M | 3.35M | 3.25M | 3.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |